Amerikanische Gesellschaft für Hirudotherapie

Ministry of Health — Independent State of Samoa

Samoa MoH · Samoa · oceania

Regulatory jurisdiction profileJurisdictional reference
Unregulatednational regulator

Samoa's Ministry of Health — leech-specific regulatory pathway has not been independently verified by ASH; medicinal leeches fall under the general national pharmaceutical and medical device framework as appropriate, with practical reliance on PIC-cooperating reference jurisdictions.

Regulatory Profile

Agency type
national regulator
Region
oceania
Country
Samoa
Leech status
unregulated
Last ASH review
2026-05-27

Relevant Regulation Codes

  • Samoan Therapeutic Goods Act 1978 (and amendments)
  • Pacific Island Countries (PIC) joint procurement arrangements through the Pacific Pharmaceutical Procurement Service where applicable

Prescriber Requirements

  • Samoa Medical Council–registered physician — order required for any biomedical device application
  • Allied health professional application under physician supervision per institutional protocol

Supply Chain & GMP

Samoa MoH registration as applicable; English-language labelling. Standard cold-chain conditions, with logistical constraints typical of remote Pacific island distribution.

Import/Export Rules

Samoa MoH and Ministry of Agriculture and Fisheries (MAF) Quarantine Division clearance for live invertebrates, complemented by SPC-recommended biosecurity practices; CITES Appendix II paperwork for Hirudo medicinalis / verbana.

Reimbursement Context

Samoa's public health system coverage depends on inpatient bundling; outpatient hirudotherapy is generally not separately reimbursed.

ASH Editorial Notes

Leech-specific pathway not independently verified by ASH; falls under general medical device / traditional medicine framework as appropriate. Pacific island nations frequently rely on Australian TGA, New Zealand Medsafe and WHO-prequalified products via Pacific cooperation arrangements; whether this captures live-organism medical devices has not been independently mapped by ASH.

Related Jurisdictions

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.